Hyperintense HCC on hepatobiliary phase images of gadoxetic acid-enhanced MRI: correlation with clinical and pathological features.

[1]  H. Edmondson,et al.  Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies , 1954, Cancer.

[2]  G. Falkson,et al.  Morphology and other prognostic factors of hepatocellular carcinoma. , 1999, Archives of pathology & laboratory medicine.

[3]  Masatoshi Tanaka,et al.  Portal vein invasion and intrahepatic micrometastasis in small hepatocellular carcinoma by gross type. , 2003, Hepatology research : the official journal of the Japan Society of Hepatology.

[4]  Maximilian F Reiser,et al.  Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT--initial observations. , 2005, Radiology.

[5]  E. Hatano,et al.  Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma , 2009, Journal of Gastroenterology.

[6]  Yong Hwan Jeon,et al.  Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. , 2009, AJR. American journal of roentgenology.

[7]  M. Choti,et al.  Predictors of Survival After Resection of Early Hepatocellular Carcinoma , 2009, Annals of surgery.

[8]  Joon Seok Lim,et al.  Diffusion-weighted MR imaging of liver on 3.0-Tesla system: effect of intravenous administration of gadoxetic acid disodium , 2010, European Radiology.

[9]  C. Loddenkemper,et al.  Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA. , 2009, AJR. American journal of roentgenology.

[10]  Myeong-Jin Kim,et al.  Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma. , 2010, Radiology.

[11]  Tonsok Kim,et al.  Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging--correlation with expression of sinusoidal and canalicular transporters and bile accumulation. , 2010, Radiology.

[12]  C. Catalano,et al.  Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis. , 2010, Radiology.

[13]  Myeong-Jin Kim,et al.  Comparison of two different injection rates of gadoxetic acid for arterial phase MRI of the liver , 2010, Journal of magnetic resonance imaging : JMRI.

[14]  Osamu Matsui,et al.  Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features. , 2010, Radiology.

[15]  Elmar M Merkle,et al.  Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver. , 2010, AJR. American journal of roentgenology.

[16]  H. Honda,et al.  Uptake of Gd-EOB-DTPA by hepatocellular carcinoma: radiologic-pathologic correlation with special reference to bile production. , 2011, European Journal of Radiology.

[17]  S. Arii,et al.  Gene Expression Signature of the Gross Morphology in Hepatocellular Carcinoma , 2011, Annals of surgery.

[18]  Myeong-Jin Kim,et al.  Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI. , 2011, AJR. American journal of roentgenology.

[19]  S. Kumano,et al.  Optimal scanning protocol of arterial dominant phase for hypervascular hepatocellular carcinoma with gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced MR , 2011, Journal of magnetic resonance imaging : JMRI.

[20]  Chang Hee Lee,et al.  Paradoxical high signal intensity of hepatocellular carcinoma in the hepatobiliary phase of Gd-EOB-DTPA enhanced MRI: initial experience. , 2011, Magnetic resonance imaging.